Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025
Bioventus (Nasdaq: BVS), a global leader in innovations for active healing, has scheduled its first quarter fiscal year 2025 financial results announcement for May 6, 2025, before market opening. The company will host a conference call at 8:30 a.m. Eastern Time on the same day, where management will discuss the results and provide a business update.
Investors can participate by dialing 1-833-636-0497 and referencing the Bioventus Conference Call. A live webcast and accompanying materials will be available on the company's investor relations website, with replay access until May 5, 2026.
Bioventus (Nasdaq: BVS), leader globale nelle innovazioni per la guarigione attiva, ha programmato l'annuncio dei risultati finanziari del primo trimestre dell'anno fiscale 2025 per il 6 maggio 2025, prima dell'apertura dei mercati. La società terrà una conference call alle 8:30 a.m. ora Eastern dello stesso giorno, durante la quale il management discuterà i risultati e fornirà un aggiornamento sull'andamento aziendale.
Gli investitori potranno partecipare chiamando il numero 1-833-636-0497 e facendo riferimento alla Conference Call Bioventus. Una trasmissione in diretta e i materiali correlati saranno disponibili sul sito web delle relazioni con gli investitori della società, con accesso alla registrazione fino al 5 maggio 2026.
Bioventus (Nasdaq: BVS), líder mundial en innovaciones para la curación activa, ha programado el anuncio de sus resultados financieros del primer trimestre del año fiscal 2025 para el 6 de mayo de 2025, antes de la apertura del mercado. La empresa realizará una llamada conferencia a las 8:30 a.m. hora del Este el mismo día, donde la dirección discutirá los resultados y ofrecerá una actualización del negocio.
Los inversores podrán participar llamando al 1-833-636-0497 y mencionando la Conferencia Telefónica de Bioventus. Una transmisión en vivo y materiales complementarios estarán disponibles en la página web de relaciones con inversores de la compañía, con acceso a la repetición hasta el 5 de mayo de 2026.
Bioventus (나스닥: BVS)는 활동적인 치유 혁신 분야의 글로벌 선두주자로서, 2025 회계연도 1분기 재무 실적 발표를 2025년 5월 6일 시장 개장 전으로 예정했습니다. 회사는 같은 날 동부 표준시 오전 8시 30분에 컨퍼런스 콜을 진행하며, 경영진이 실적을 설명하고 사업 현황을 업데이트할 예정입니다.
투자자들은 1-833-636-0497로 전화하여 Bioventus 컨퍼런스 콜을 참조해 참여할 수 있습니다. 생중계와 관련 자료는 회사의 투자자 관계 웹사이트에서 제공되며, 2026년 5월 5일까지 다시보기가 가능합니다.
Bioventus (Nasdaq : BVS), leader mondial des innovations pour la guérison active, a programmé l'annonce de ses résultats financiers du premier trimestre de l'exercice 2025 pour le 6 mai 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique à 8h30, heure de l'Est le même jour, où la direction présentera les résultats et fournira une mise à jour sur les activités.
Les investisseurs peuvent participer en composant le 1-833-636-0497 et en mentionnant la conférence téléphonique Bioventus. Une diffusion en direct ainsi que les documents associés seront disponibles sur le site des relations investisseurs de la société, avec un accès au replay jusqu'au 5 mai 2026.
Bioventus (Nasdaq: BVS), ein weltweit führendes Unternehmen für Innovationen im Bereich der aktiven Heilung, hat die Bekanntgabe der Finanzergebnisse für das erste Quartal des Geschäftsjahres 2025 für den 6. Mai 2025 vor Handelsbeginn geplant. Das Unternehmen wird am selben Tag um 8:30 Uhr Eastern Time eine Telefonkonferenz abhalten, in der das Management die Ergebnisse erläutert und ein Geschäftsupdate gibt.
Investoren können teilnehmen, indem sie die Nummer 1-833-636-0497 anrufen und auf die Bioventus-Konferenzschaltung verweisen. Ein Live-Webcast und begleitende Materialien stehen auf der Investor-Relations-Website des Unternehmens zur Verfügung, mit Zugriff auf die Aufzeichnung bis zum 5. Mai 2026.
- None.
- None.
DURHAM, N.C., April 28, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the first quarter of fiscal year 2025 before the market opens on Tuesday, May 6, 2025. The Company’s management will host a conference call at 8:30 a.m. Eastern Time that same day to discuss the results and provide a business update.
To participate in the conference call, dial 1-833-636-0497 and refer to the Bioventus Inc. Conference Call.
A live webcast of the call and accompanying materials will also be provided on the “Investor Relations” section of the Company's website at https://ir.bioventus.com/. The webcast will be archived at the same site and available for replay until May 5, 2026.
About Bioventus
Bioventus delivers clinically proven, cost-effective products that help people heal quickly and safely. Its mission is to make a difference by helping patients resume and enjoy active lives. The Innovations for Active Healing from Bioventus include offerings for Pain Treatments, Restorative Therapies and Surgical Solutions. Built on a commitment to high quality standards, evidence-based medicine and strong ethical behavior, Bioventus is a trusted partner for physicians worldwide. For more information, visit www.bioventus.com and follow the Company on LinkedIn and Twitter. Bioventus and the Bioventus logo are registered trademarks of Bioventus LLC.
Investor and Media Inquiries:
Dave Crawford
919-474-6787
Dave.Crawford@bioventus.com
FAQ
When will Bioventus (BVS) release Q1 2025 earnings?
How can investors join the Bioventus (BVS) Q1 2025 earnings call?
How long will the Bioventus (BVS) Q1 2025 earnings webcast be available?
Where can I find Bioventus (BVS) Q1 2025 earnings materials?
